Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Carcinoma and BW4[original query] |
---|
KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population. Human immunology 2012 Jul . Wi?niewski A, Jankowska R, Passowicz-Muszy?ska E, Wi?niewska E, Majorczyk E, Nowak I, Frydecka I, Ku?nierczyk P |
Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy. Cancer immunology research 2014 Dec 2 (12): 1142-7. Tanimine Naoki, Tanaka Yuka, Kobayashi Tsuyoshi, Tashiro Hirotaka, Miki Daiki, Imamura Michio, Aikata Hiroshi, Tanaka Junko, Chayama Kazuaki, Ohdan Hide |
Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells. Cancer research 2016 Jan . Vineretsky Karin A, Karagas Margaret R, Christensen Brock C, Kuriger-Laber Jacquelyn K, Perry Ann E, Storm Craig A, Nelson Heather |
KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients. Oncotarget 2018 Apr 9 (28): 19650-19661. Saito Hiromi, Umemura Takeji, Joshita Satoru, Yamazaki Tomoo, Fujimori Naoyuki, Kimura Takefumi, Komatsu Michiharu, Matsumoto Akihiro, Tanaka Eiji, Ota Mas |
KIR/HLA ligands immunogenetics markers associated with outcome of hepatitis B virus infection in the Bulgarian population. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2020 9 165 (3): 270-276. Varbanova Viktoria, Popov Georgi, Grigorova Veneta, Petrova Diana, Naumova Elissaveta, Mihaylova Anastasi |
Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients. Scientific reports 2021 11 11 (1): 21424. Joshita Satoru, Ota Masao, Kobayashi Hiroyuki, Wakabayashi Shun-Ichi, Yamashita Yuki, Sugiura Ayumi, Yamazaki Tomoo, Tanaka Eiji, Umemura Take |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: